Mirna M. Abboud

Radiation Oncology
501 W Medical Center Blvd
Webster, TX 77598

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation.

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation.

Journal: Radiation oncology (London, England)
Published: June 01, 2017
Showing 1-1 of 1

Last Updated: 09/26/2026